Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
AD ArrayDigital Q4 2025 EPS misses estimates by 33 sending shares down 137 in todays trading The analysis identifies three distinct risk tiers within the REIT ecosystem Is Duke Energy DUK stock worth adding to a portfolio Q4 2025 Profit Disappoints Figure FIGR Stock Growth Opportunities Risk Aversion 20260420 New York Magazine Investigates HighProfile Writer Over Plagiarism Allegations Ahead of Book Release on Mayor Mamdani Car Subscription Services Stalled But Consumer Demand for Flexible Mobility Models Grows UAE Investigates Strike Near Barakah Nuclear Plant Raising Regional Energy Security Concerns Labours Social Care Challenge Economic Implications of Ageing Population Policy Shift Canadas Big Banks Set to Report Solid Q2 But Soft Economic Outlook May Steer Investor Attention South Koreas Deputy PM Warns AI Could Worsen Wealth Inequality Amid Samsung Labor Disputes Gaza Flotilla Detainee Allegations Could Impact Israels International Relations and Economic Stability Capgemini Outlines Strategic Plan to Capture AI Growth Opportunities Through 2028 Market Pricing Shifts Federal Reserve Rate Hike Prospects Rise After Hot Inflation Data Vestas Shares Slide After Company Flags Margins at Low End of Guidance Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline SFL Q1 2026 Earnings Monumental EPS Surprise Overshadowed by Share Decline MasTec MTZ Q1 2026 Earnings Strong EPS Beat Drives Optimism Despite Stock Dip WMB Q1 2026 Earnings EPS Miss Weighs on Stock Natural Gas Infrastructure Firm Faces Profitability Headwinds RenX Enterprises Corp RENX Q1 2026 Earnings EPS Misses Estimates by 264 Stock Rises 063 Amid Investor Optimism ChipMOS IMOS Q1 2026 Earnings EPS Misses Expectations as Shares Edge Higher EverCommerce EVCM Gains 23 as Shares Approach Key Resistance Level XMAX Inc XWIN Holds Steady at 824 as Market Awaits Catalyst Odysightai ODYS Surges Over 4 as Buyers Defend Key Support Level Contineum Therapeutics CTNM Declines 355 Testing Key Support at 1317 BKV Corporation Edges Lower After Recent Rally Tests Key Support Levels